Stimulation of Human Granulocyte Function by Monoclonal Antibody WEM-G1
Overview
Affiliations
From a panel of monoclonal antibodies (MAb) produced against purified human neutrophils, MAb WEM-G1 was selected for its ability to stimulate granulocyte function as assessed by the capacity to kill antibody-coated tumor target cells. MAb WEM-G1 bound to neutrophils and eosinophils and not to monocytes, lymphocytes, or erythrocytes, and thus identified a granulocyte differentiation antigen. It enhanced killing by both neutrophils and eosinophils in a dose-dependent fashion, with a range of effector-to-target ratios and dilutions of anti-target cell antibody. The effect of MAb WEM-G1 was additive with that of colony-stimulating factor (CSF-alpha). Similarly, the ability of neutrophils to exhibit enhanced cytotoxicity in the presence of WEM-G1 was increased by preincubation of neutrophils with CSF-alpha. Immunoprecipitation analysis showed that WEM-G1 identified a cell-surface protein on human neutrophils of approximate molecular weight 110,000. It is suggested that this structure is involved in regulation of the function of human granulocytes.
Plasma membrane antigens on light density and activated human blood eosinophils.
Tai P, Bakes D, Barkans J, Spry C Clin Exp Immunol. 1985; 60(2):427-36.
PMID: 4006306 PMC: 1577022.
Eosinophilic disorders affecting the myocardium and endocardium: a review.
Spry C, Take M, Tai P Heart Vessels Suppl. 1985; 1:240-2.
PMID: 3916474 DOI: 10.1007/BF02072402.
New properties and roles for eosinophils in disease: discussion paper.
Spry C J R Soc Med. 1985; 78(10):844-8.
PMID: 3900398 PMC: 1289951. DOI: 10.1177/014107688507801011.
Vadas M, Lopez A, Williamson D Proc Natl Acad Sci U S A. 1985; 82(8):2503-7.
PMID: 3887404 PMC: 397587. DOI: 10.1073/pnas.82.8.2503.
Tai P, Capron M, Bakes D, Barkans J, Spry C Clin Exp Immunol. 1986; 63(3):728-37.
PMID: 3708911 PMC: 1577539.